United Kingdom renal denervation market
is anticipated to register growth with an impressive CAGR in the forecast
period, 2023-2027. The market growth can be attributed to growing instances of
hypertension. Growing complexities of the hypertension disorders and its
adverse effect on the kidney functioning drives the growth of the United
Kingdom renal denervation market in the upcoming five years. Growing
advancement in the medical devices supportive of the renal denervation
procedure also fuel the growth of the United Kingdom renal denervation market
in the next five years.
Renal denervation (RDN) is a minimally invasive procedure to treat therapeutic resistant
hypertension. Under the circumstances where hypertension conditions do not
respond to aggressive medical treatment that may arise due to either patient
taking different blood pressure medications at the highest capacity of the
drugs or if the medication is diuretic that means it removes the fluids and
salt from the body that is hindering with the renal functions. The procedure
uses radiofrequency ablation to burn the nerves in the renal arteries. This
process causes a reduction in the nerve activity, which decreases blood
pressure.
Surging Number of Hypertension Patients
Promises Market Growth
Rapidly increasing number of patients
suffering from the hypertension and high blood pressure drive the growth of the
United Kingdom renal denervation market in the upcoming five years. Prolonged
food habits, sedentary lifestyle, and growing consumption of alcohol and
smoking instances enhance the risks of hypertension and high blood pressure as well as
disturbing the normal kidney functions too, thereby facilitating the growth of
the United Kingdom renal denervation market in the next five years.
High blood pressure affects more than 1
in 4 adults in England, around 12.5 million people in 2015. The prevalence of
high blood pressure for adults in England in 2015 was 31% among men and 26%
among women, with little change over the last few years. Furthermore,
technologically advanced equipment and medical devices flooding the healthcare industry in the
country also substantiate the growth of the United Kingdom renal denervation
market in the future five years.
Click here to download the sample
Market Segmentation
The United
Kingdom renal denervation market is segmented by technology, product, therapeutic
area, end user, competitional landscape, and regional distribution. Based on technology, the market is
further segmented into ultrasound ablation, radiofrequency ablation,
pharmacologic ablation, and micro-infusion. By product, the market is
fragmented into catheters, single electrode catheter, multi electrode catheter,
RF generator, and others. Based on therapeutic area, the market is
differentiated into hypertension, heart failure, diabetes, renal failure, and others.
By end user, the market is further bifurcated into hospitals & clinics,
ambulatory care centers, and other. The market analysis also studies the
regional segmentation to devise regional market segmentation, divided among London,
East Anglia, Southwest, Southeast, Scotland, East Midlands, and Yorkshire &
Humberside.
Company Profile
Medtronic United Kingdom, Boston
Scientific Limited, Abbott Laboratories Limited, CardioSonic Limited, Terumo UK
Limited, Johnson & Johnson Limited,
among others is a partial list of major market players of the companies
responsible for the growth of United Kingdom renal denervation market.
|
Attribute
|
Details
|
|
Base Year
|
2021
|
|
Historical Data
|
2017 –
2020
|
|
Estimated Year
|
2022
|
|
Forecast Period
|
2023
– 2027
|
|
Quantitative Units
|
Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027
|
|
Report coverage
|
Revenue
forecast, company share, competitive landscape, growth factors, and trends
|
|
Segments covered
|
·
Technology
·
Product
·
Therapeutic Area
·
End User
|
|
Regional scope
|
London, East Anglia, Southwest, Southeast, Scotland, East
Midlands, and Yorkshire & Humberside
|
|
Key companies profiled
|
Medtronic United Kingdom, Boston Scientific Limited, Abbott
Laboratories Limited, CardioSonic Limited, Terumo UK Limited, Johnson &
Johnson Limited
|
|
Customization scope
|
10%
free report customization with purchase. Addition or alteration to country,
regional & segment scope.
|
|
Pricing and purchase options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase options
|
|
Delivery Format
|
PDF and Excel through Email (We can also
provide the editable version of the report in PPT/Word format on special
request)
|
Report Scope:
In this report, United Kingdom renal denervation market has been segmented into
following categories, in addition to the industry trends which have also been
detailed below:
- United Kingdom Renal Denervation Market,
By Technology:
- Ultrasound Ablation
- Radiofrequency Ablation
- Pharmacologic Ablation
- Micro-infusion
- United Kingdom Renal Denervation Market,
By Product:
- Catheters
- Single Electrode Catheter
- Multi Electrode Catheter
- RF Generator
- Others
- United Kingdom Renal Denervation Market,
By Therapeutic Area:
- Hypertension
- Heart Failure
- Diabetes
- Renal Failure
- Others
- United Kingdom Renal Degeneration
Market, By End User:
- Hospitals & Clinics
- Ambulatory Care Centers
- Others
- United Kingdom Renal Denervation Market,
By Region:
o London
o East Anglia
o Southwest
o Southeast
o Scotland
o East Midlands
o Yorkshire & Humberside
Competitive Landscape
Company
Profiles: Detailed
analysis of the major companies present in United Kingdom renal denervation market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company
Information
Detailed analysis and
profiling of additional market players (up to five).United Kingdom Renal Denervation Market is an upcoming report to be
released soon. If you wish an early delivery of this report or want to confirm
the date of release, please contact us at [email protected]